Historically, longevity medicine overlooked women's unique biology, resulting in dismissed symptoms and inadequate care, especially for those over 35 due to a male-default research bias. This systemic gap often misses critical female biomarkers and the significant hormonal shifts of perimenopause, leading to a disconnect between how women feel and their "normal" lab results. Discover why a personalized, hormone-aware approach is essential for women seeking effective longevity strategies tailored to their specific health needs.